Here are some articles that caught my eye this morning: A promising cancer treatment made patients worse, not better. A Biotech Entrepreneur Aims To Help Us Stay Young While Growing Old Notorious activist investor Carl Icahn buys small stake in Allergan ASCO18: Who were the big winners and losers? Virtual Surgery: no longer a question … Continue reading Thursday Morning Reads →